• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Med Virol . Development and validation of a simplified nomogram predicting individual critical illness of risk in COVID-19: a retrospective study

tetano

Editor, Senior Moderator
J Med Virol


. 2020 Sep 25.
doi: 10.1002/jmv.26551. Online ahead of print.
Development and validation of a simplified nomogram predicting individual critical illness of risk in COVID-19: a retrospective study


Ranran Xu[SUP] 1 [/SUP], Junwei Cui[SUP] 2 [/SUP], Liu Hu[SUP] 3 [/SUP], Yiru Wang[SUP] 1 [/SUP], Tao Wang[SUP] 4 [/SUP], Dawei Ye[SUP] 5 [/SUP], Yongman Lv[SUP] 1 3 [/SUP], Qingquan Liu[SUP] 1 [/SUP]



Affiliations

Abstract

Background: This study aims to screen useful predictors of critical cases among COVID-19 patients and to develop a simple-to-use nomogram for clinical utility.
Methods: A retrospective study was conducted that consisted of a primary cohort with 315 COVID-19 patients and two validation cohorts with 69 and 123 patients, respectively. Logistic regression analyses were used to identify independent risks of progression to critical. An individualized prediction model was developed, and calibration, decision curve, and clinical impact curve were used to assess the performance of the model. External validations for the predictive nomogram were also provided.
Results: The variables of age, comorbid diseases, neutrophil-to-lymphocyte ratio, D-Dimer, C-reactive protein, and platelet count were estimated to be independent predictors of progression to critical, which were incorporated to establish a model of the nomogram. It demonstrated good discrimination (with a C-index of 0.923) and calibration. Good discrimination (C-index, 0.882 and 0.906) and calibration were also noted on applying the nomogram in two validation cohorts. The clinical relevance of the nomogram was justified by the decision curve and clinical impact curve analysis.
Conclusions: This study presents an individualized prediction nomogram incorporating six clinical characteristics, which can be conveniently applied to assess an individual's risk of progressing to critical COVID-19. This article is protected by copyright. All rights reserved.

Keywords: COVID-19; Coronavirus; Critical; Nomogram; Prediction model.
 
Back
Top Bottom